XOMA Royalty Corp
Acquires biotech drug royalties to provide non-dilutive funding for pharma & biotech firms.
XOMA | US
Overview
Corporate Details
- ISIN(s):
- US98419J3059 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 2200 POWELL STREET, 94608 EMERYVILLE
- Website:
- https://xoma.com/
- Sector:
- Financial and insurance activities
- Industry:
- Other financial service activities, except insurance and pension funding activities
Description
XOMA Royalty Corp. is a biotech royalty aggregator that acquires economic rights to future milestone and royalty payments associated with pre-commercial and partnered drug candidates. The company provides non-dilutive, non-recourse funding to biotech and pharmaceutical firms, enabling them to advance their internal drug development programs. XOMA manages a diverse and growing portfolio of over 120 assets, a strategy designed to mitigate the risks associated with single-asset clinical trials. Originally a drug development company, XOMA pivoted in 2017 to focus exclusively on its royalty aggregation business model.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all XOMA Royalty Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for XOMA Royalty Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for XOMA Royalty Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
